Company Monitoring Page for Novo-Nordisk

latest headlines for company on cafepharma

Novo Nordisk, Eli Lilly poised to divvy up obesity market that could be worth $50B in 2030: analysts
Fierce Pharma
Sun, 07/17/22 - 11:07 pm
Tags:
Eli Lilly, Novo Nordisk, obesity
Marinus Pharma Shares Up After Deal for Rare Pediatric Disease Priority Review Voucher
Morningstar
Thu, 07/14/22 - 10:49 am
Tags:
Marinus Pharmaceuticals, priority review vouchers, pediatrics, Novo Nordisk
Vivus’ Qsymia beats out weight loss competitors in pricing watchdog's latest cost-effectiveness analysis
Endpoints
Wed, 07/13/22 - 08:22 pm
Tags:
Vivus, Qsymia, weight loss, ICER, Novo Nordisk, Saxenda, Wegovy
Novo Nordisk A/S: Phase 3 data for concizumab show 86% reduction in treated bleeds in haemophilia A or B with inhibitors
Yahoo Finance
Sun, 07/10/22 - 11:51 pm
Tags:
Novo Nordisk, concizumab, hemophilia
Novo Nordisk workers in Korea protest after breakdown in salary and perks negotiations — report
Endpoints
Thu, 07/7/22 - 06:24 pm
Tags:
Novo Nordisk, unions, South Korea
After phase 2 flop, Novo Nordisk says its NASH work is 'still very much on track'
Fierce Pharma
Wed, 06/29/22 - 05:43 pm
Tags:
Novo Nordisk, NASH, semaglutide
Innovent catching up with Lilly, Novo Nordisk thanks to phase 2 obesity data
Fierce Biotech
Wed, 06/8/22 - 10:34 am
Tags:
Innovent, Eli Lilly, Novo Nordisk, obesity, clinical trials, mazdutide
Novo Scores Phase III Insulin Win, Potentially Strengthening Market Position
BioSpace
Sun, 06/5/22 - 11:38 pm
Tags:
Novo Nordisk, insulin, clinical trials, insulin icodec, diabetes
Eli Lilly, Novo Nordisk and Sanofi face new lawsuit from Arkansas AG over insulin prices
Fierce Pharma
Thu, 05/12/22 - 10:54 pm
Tags:
Eli Lilly, Novo Nordisk, Sanofi, Arkansas, insulin, drug pricing, PBMs, diabetes
How Novo Nordisk Will Protect Insulin Sales
Motley Fool
Thu, 05/12/22 - 10:27 am
Tags:
Novo Nordisk, insulin, diabetes, drug pricing, Affordable Insulin Now Act
Novo Nordisk forges close ties with biotech VC Flagship
Pharmaforum
Wed, 05/11/22 - 10:39 am
Tags:
Novo Nordisk, R&D, Flagship Pioneering, venture capital
Novo's Wegovy supply rebound on track for later this year as demand stays strong
Fierce Pharma
Mon, 05/2/22 - 11:04 am
Tags:
Novo Nordisk, obesity, Wegovy
Novo Nordisk once-weekly insulin clears first phase 3 test
Pharmaforum
Fri, 04/29/22 - 10:33 am
Tags:
Novo Nordisk, diabetes, type 2 diabetes, insulin, insulin icodec, once-weekly insulin, clinical trials
5 Big Pharma, Biotech Stocks Set to Beat Q1 Earnings Estimates
Yahoo/Zacks.com
Fri, 04/29/22 - 10:17 am
Tags:
COVID-19, earnings, Novo Nordisk, Biogen, Regeneron, Moderna Therapeutics, Vertex Pharmaceuticals
Lilly's tirzepatide clears high bar set by Novo's Wegovy in obesity
Fierce Biotech
Thu, 04/28/22 - 10:53 am
Tags:
Eli Lilly, tirzepatide, obesity, Wegovy, Novo Nordisk
Novo Nordisk snags high-dose Ozempic approval, turning up the heat on Lilly's Trulicity
Fierce Pharma
Wed, 03/30/22 - 11:11 am
Tags:
Novo Nordisk, Ozempic, diabetes, FDA, Eli Lilly, Trulicity
Big pharma’s key second-quarter data
EP Vantage
Tue, 03/29/22 - 10:32 am
Tags:
Roche, tiragolumab, Giredestrant, Sanofi, Eli Lilly, tirzepatide, Novo Nordisk, GSK, Pfizer, RSV
Novo Nordisk and Novartis put Victoza patent suit to bed, teeing up Sandoz copycat by 2024
Fierce Pharma
Wed, 03/23/22 - 10:38 am
Tags:
Novo Nordisk, Novartis, Sandoz, Victoza, generics, patents, diabetes
Novo Nordisk adds bioelectronics, biosensors and stimuli-responsive delivery devices to scope of MIT pact
Fierce Pharma
Tue, 03/15/22 - 10:43 am
Tags:
Novo Nordisk, drug delivery, bioelectronics, biosensors, MIT, Brigham and Women's
Novo Nordisk extends innovative drug delivery research tie-up with MIT and BWH
Biopharma Reporter
Wed, 03/9/22 - 10:58 am
Tags:
Novo Nordisk, R&D, MIT, Brigham and Women's, drug delivery

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.